Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

Search


Following Uptick In 2023, Bankruptcy Lawyers Are Expecting a Busy 2024
January 01, 2024
Predictions of an uptick in bankruptcy filings came true this year, and bankruptcy lawyers are expecting a steady continuation into 2024, with the use of alternative approaches continuing to increase.
Fed Holds Rates and Signals Cuts In 2024
January 01, 2024
The news is good. However, it doesn't look like what some in CRE might want, which is a return to ultra-low interest rates and high leverage.
Lack of Transparency In SEC Settlement Penalty Calculations May Frustrate Self-reporting
January 01, 2024
SEC settlements often lack explanation as to how the civil monetary penalties were calculated per the statutory framework or why such penalties were appropriate under the circumstances. This lack of transparency tends to create market confusion and may frustrate certain behavior the SEC seeks to encourage, namely self-reporting.
The Bankruptcy Strategist Is Going Digital Only. Here's What You Need to Know.
January 01, 2024
The final print edition of The Bankruptcy Strategist will be our January issue.
Entertainment Law & Finance Is Going Digital Only. Here's What You Need to Know.
January 01, 2024
The final print edition of Entertainment Law & Finance will be our January issue.
Accounting and Financial Planning for Law Firms Is Going Digital Only. Here's What You Need to Know.
January 01, 2024
The final print edition of Accounting and Financial Planning for Law Firms will be our January issue.
Commercial Leasing Law & Strategy Is Going Digital Only. Here's What You Need to Know.
January 01, 2024
The final print edition of Commercial Leasing Law & Strategy will be our January issue.
Business Crimes Bulletin Is Going Digital Only. Here's What You Need to Know.
January 01, 2024
The final print edition of Business Crimes Bulletin will be our January issue.
The Importance of Cyber Vigilance: Control Liability and Litigation Exposure
December 01, 2023
This article covers cyber trends and tips for organizations to explore in order to be better equipped to anticipate and respond to cyber incidents before a devastating breach occurs. The outcome? Diminished chance of class action activity, compliance violations, lost business, and mounting costs.
Fighting Cybercrime With Cyberaccounting
December 01, 2023
As cybercrime intensifies, it is revealing a skills shortfall among those who defend our financial infrastructure. It has become critically clear that we need to radically rethink the way we prepare our frontline defense to include more experts with both technical savvy and accounting expertise. In other words, we need an army of cyber accountants.

MOST POPULAR STORIES

  • Surveys in Patent Infringement Litigation: The Next Frontier
    Most experienced intellectual property attorneys understand the significant role surveys play in trademark infringement and other Lanham Act cases, but relatively few are likely to have considered the use of such research in patent infringement matters. That could soon change in light of the recent admission of a survey into evidence in <i>Applera Corporation, et al. v. MJ Research, Inc., et al.</i>, No. 3:98cv1201 (D. Conn. Aug. 26, 2005). The survey evidence, which showed that 96% of the defendant's customers used its products to perform a patented process, was admitted as evidence in support of a claim of inducement to infringe. The court admitted the survey into evidence over various objections by the defendant, who had argued that the inducement claim could not be proven without the survey.
    Read More ›
  • In the Spotlight
    On May 9, 2003, the U.S. Attorney's Office for the District of Massachusetts announced that Bayer Corporation, the pharmaceutical manufacturer, had been sentenced and ordered to pay a criminal fine of $5,590,800 stemming from its earlier plea of guilty to violating the Federal Prescription Drug Marketing Act by failing to list with the FDA its drug product, Cipro, that was privately labeled for an HMO. Such listing is required under the federal Food, Drug &amp; Cosmetic Act. The Federal Prescription Drug Marketing Act, Pub. L. 100-293, enacted on April 22, 1988, as modified on August 26, 1992 by the Prescription Drug Amendments (PDA) Pub. L. 102-353, 106 Stat. 941, amended sections 301, 303, 503, and 801 of the Federal Food, Drug, and Cosmetic Act, codified at 21 U.S.C. '' 331, 333, 353, 381, to establish requirements for distributing prescription drug samples.
    Read More ›